Why most hospitals could save millions by improving patient safety

by Erik Johnson, VigiLanz CCO

Improving patient safety and increasing the bottom line aren’t competing priorities. Here’s how hospitals can accomplish both objectives.

The first wave of Covid-19 may gave subsided in some areas of the country, but in others it is growing and hospitals everywhere are continuing to face significant challenges.

The American Hospital Association recently estimated that hospitals will incur at least $323.1 billion in losses through the end of this year due to Covid-19. Key contributors include postponed and canceled elective procedures, lower patient volumes across all departments, and higher costs for supplies and devices.

Other factors compound the financial challenges, including pressure for hospitals to implement new initiatives that foster a safer care environment for Covid-19 patients, non-Covid-19 patients, and healthcare providers. This pressure is mounting, as spikes in cases continue to appear in various regions, and as concerns grow about the flu season.

You can read more of this article on MedCityNews.  

A Message from David Goldsteen, MD, VigiLanz CEO

To our hospital partners and healthcare providers,

Thank you for the long hours you are working, the risks you are taking, and the sacrifices you are making to care for patients with COVID-19. VigiLanz is here to support you in any way that we can.

Over the past few weeks, you’ve shared some of your top challenges with us. We’ve also gathered insights from our internal clinical team. Based on these discussions, we’re enabling new COVID-19 related rules, reports, and alerts almost daily and supporting custom requests based on the unique needs of each hospital.

We’ve also created a new COVID-19 Testing Results report. This report compiles all patients with a COVID-19 order, positive/negative lab result, or positive microbiology report. In addition, it includes patient demographics, clinical parameters like temperature, SpO2, FiO2, medications, and discharge disposition. As with all of our reports, it can be exported to Excel after it’s generated.

As the COVID-19 crisis evolves and your needs change, we will continue to reach out and identify new ways to help. We’ll share that information here, on our website, and in emails.

In the meantime, please let us know if there are any other ways we can support you.

With gratitude for the important work you’re doing.


David Goldsteen, MD, MBA
Chairman & CEO, VigiLanz

VigiLanz Ranked No. 1 by KLAS Research Across Three Categories for the Third Year

Clinical surveillance company recognized again as a KLAS leader in antimicrobial stewardship, infection control and monitoring, and pharmacy surveillance


MINNEAPOLIS – Feb. 4, 2020 – VigiLanz, a clinical surveillance company, today announced that it has earned 2020 Category Leader designations from KLAS Research for Antimicrobial Stewardship, Infection Control and Monitoring, and Pharmacy Surveillance. This is the second year VigiLanz has been recognized by KLAS as a Category Leader across all three areas, and the third year to earn that distinction in Infection Control and Monitoring and Pharmacy Surveillance, prior to the Antimicrobial Stewardship category being added in 2019.

Three VigiLanz products were recognized in the “2020 Best in KLAS: Software and Services” report, released on January 31:

VigiLanz Dynamic Infection Control Monitor

Earning a score of 92.7, the Dynamic Infection Control Monitor is a seamless, real-time automated monitoring system that works with an organization’s EHR. Its automatic exception-based alert system puts all patient records under continuous surveillance to alert decision makers in real time of potential infections, MDROs, isolation candidates, organism clusters, conditions of concern, and reportable infections. The surveillance is based on a sophisticated set of customizable rule engines.

“I really like the ability to adapt the rules in Dynamic Infection Control Monitor. Interpreting rules is much easier now than it was with our last system. My infection control team is not super tech savvy, and my people have other tasks and jobs to worry about. The system makes doing their jobs easy for them.”

  • Manager, August 2019, klasresearch.com  

VigiLanz Dynamic PharmacoVigilance

Earning a score of 92.8, Dynamic PharmacoVigilance acts as a bridge between a hospital’s pharmacy and lab information systems, automating the comparison of patients’ drug usage with lab results, then presenting the potential for Adverse Drug Event reduction. Based on the system’s built-in rule sets or hospital-specific guidelines, it automatically generates warnings and alerts that help clinicians make appropriate drug therapy decisions.

“The versatility of the VigiLanz system is its strength. We have been able to leverage rule abilities on many fronts. The product is excellent. It does a great job with tasking and the workflow of identifying patients. The product is very robust.”

  • Analyst/Coordinator, August 2019, com

VigiLanz Antimicrobial Stewardship

Earning a score of 93.3, the Antimicrobial Stewardship product monitors antimicrobial therapy to ensure appropriate use, including unnecessary antibiotic therapy, de-escalation opportunities, positive rapid diagnostic test results, drug-bug mismatches, and opportunities for antibiotic “time-outs.” The Antimicrobial Stewardship dashboard shows usage and resistance trends across the organization, is Meaningful Use 3 certified, and provides direct reporting to the Centers for Disease Control’s National Healthcare Safety Network.

“VigiLanz doesn’t provide software where we have to fill in the blanks. The software has a framework that allows us to create our own world. The software is limitless. In this ever-changing world, the VigiLanz product is what we need for healthcare.”

  • Director, November 2019, klasresearch.com

“Our customers’ trust in our clinical surveillance products is the highest level of affirmation we can achieve,” said VigiLanz Chairman and CEO David Goldsteen, MD. “We strive to exceed our customers’ expectations year over year. We are proud to be recognized as a Category Leader for three years running. To the customers who asserted their confidence in us and our products – thank you. We will continue to set the bar higher and support you in building healthier hospitals.”

The KLAS Category Leader designation is awarded to vendors that lead select market segments in which at least two products meet a minimum number of KLAS Konfidence reviews. Rankings are based on customer surveys of North American healthcare leaders, administrators, clinicians, and others who interact with the solutions.




About KLAS

KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers and payers to be heard and counted. Working with thousands of healthcare professionals, KLAS gathers insights on software, services and medical equipment to deliver timely reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly represents the voice of healthcare professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and the insights we provide, visit www.KLASresearch.com.


About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care.

How Children’s Minnesota Successfully Managed a Measles Outbreak

Health providers across the country must react quickly and proactively if an outbreak occurs in their area, but it’s not an easy undertaking.

Although measles was declared eliminated in the United States in 2000, measles is still endemic in many areas of the world. Public health officials and healthcare providers know that a new measles outbreak in the U.S. could ignite at any moment when communities of susceptible individuals combine with easily accessible, rapid international travel. This is the situation in several jurisdictions, where recent outbreaks have resulted in the largest number of confirmed measles cases the U.S. has seen in 25 years, according to the CDC.

Clinics, hospitals, and healthcare systems across the country must be prepared to act quickly if an outbreak occurs in their area, but it’s not an easy undertaking.

At the 2019 APIC conference in Philadelphia, attendees had the chance to hear from Jennifer Boe, BSN, RN, PHN, CIC, an infection preventionist at Children’s Minnesota, and Joe Kurland, MPH, CIC, an infection preventionist and vaccine specialist at Children’s Minnesota, who helped quell a measles outbreak in their community in 2017.

Just before the conference, we caught up with them to learn more about what they would be presenting during their session.

VigiLanz: How did the measles outbreak develop in your community? What type of situation was your hospital facing?

Boe and Kurland: We have a large, vibrant Somali community here in Minnesota, centered in the Twin Cities metro area, and they frequently travel to places where measles is endemic. Back in 2004, the MMR vaccination rate for the Somali-Minnesotan community was about 92 percent. Around 2006, and in response to the Somali community’s perception of increased and disproportionate rates of autism without a known cause, the community was subjected to targeted anti-vaccine messaging. As a result, the MMR rate among Somali-Minnesotan children plummeted to a low of 42 percent. With low community immunity and frequent international travel, it was only a matter of time until we had an outbreak. Our first measles case occurred in March 2017 in a Somali-Minnesotan child, and we knew immediately that we would be seeing many more cases. At Children’s Minnesota, we ended up testing 275 patients for measles between April and August. At the end of the outbreak, Minnesota had 75 confirmed cases, and Children’s had cared for 52 of them, including 22 inpatient hospitalizations.

“With low community immunity and frequent international travel, it was only a matter of time until we had an outbreak.”

VigiLanz: What were some of the first things you did to address the problem?

Boe and Kurland: Because of the low community immunity, we knew this was a public health emergency. We activated our hospital incident command system (HICS), and it was “all hands on deck.” We collaborated with our state health department, developed phone banks and a measles hotline, and prepared the emergency departments and clinics to rapidly identify and isolate suspect cases. Our infection prevention team had to reprioritize our normal work and resources in order to accommodate this outbreak response. This included rotating call every 24 hours and assigning one team member to other high-priority daily work. 

VigiLanz: What role did VigiLanz play in supporting your efforts?

Boe and Kurland: VigiLanz helped ensure that no suspect cases being tested for measles slipped through the cracks. For example, we ask providers to contact us whenever they consider ordering a measles test for a patient. At the height of the outbreak when we were testing so many patients, we found that we weren’t being notified 100 percent of the time. We worked with our VigiLanz support team member to create a new rule, which alerted us whenever a measles test was ordered. VigiLanz was able to implement this new alert for us within one day of us requesting it. Knowing about suspect cases ahead of time ensured we were in the loop, and it allowed us to identify potential exposures so we could rapidly respond if the measles test was positive. Another VigiLanz rule alerted us if a known case or exposed patient returned to our organization for care.

VigiLanz: What is one thing you will discuss during your session that you think health systems would really benefit from hearing more about?

Boe and Kurland: During our session, we’ll also discuss our exposure reduction interventions that were implemented during the outbreak, as well as our post-exposure response plan, including prophylaxis and prioritization of exposed individuals. We will also share a checklist to help organizations improve their preparedness and plan their response to a measles outbreak. Finally, we will hold a Q&A after the session, and we are excited to talk to other infection preventionists and providers about unique challenges at their health systems and share thoughts on how they might be addressed.

Event Presentation

If you missed the presentation, here’s your chance to view it. You’ll learn what led to the outbreak, how the hospital responded, and lessons learned that could benefit your own health system.

Four Ways Hospitals Use Clinical Surveillance To Improve Patient Safety

Patient safety problems, from hospital-acquired infections to medical errors, occur much too frequently. This year, 800 hospitals will incur reimbursement penalties from Medicare because of high rates of infections and patient injuries, and a recent Johns Hopkins study found that medical errors are the third leading cause of death in the U.S. after heart disease and cancer.

You can read more of this article on Health IT Outcomes.

For more on how VigiLanz can improve patient safety, click here.

VigiLanz Supports Opioid Stewardship Initiatives at Houston Methodist

Hospitals Fight Back Against the Opioid Epidemic With VigiLanz

The opioid epidemic is one of the most challenging safety problems hospitals face, and VigiLanz is helping address it. The technology alerts physicians and pharmacists if a safety issue arises, such as if a patient is prescribed multiple opioids or has been taking an opioid longer than recommended.

Houston Methodist hospital is using VigiLanz to identify duplicate opioid orders and high use areas. In a recent study, the hospital found that opioid alerts triggered by VigiLanz led to the discontinuation of one or more opioids 53% of the time.


VigiLanz Supports Program that Reduces Rate of Acute-Kidney Injury

VigiLanz Supports Innovative New Approach at Cincinnati Children’s Hospital

Nephrotoxic medications are critical for many patients. Unfortunately, they can also sometimes lead to acute-kidney injury in pediatric patients. To address this problem, Cincinnati Children’s Hospital Medical Center created a complex algorithm to identify patients at risk. The program has led to a 40 percent reduction in AKIs.

VigiLanz supports the program by monitoring patient datawith a complex set of exposure criteria and alerting providers in near real-time if a patient has been exposed to nephrotoxins. It also lets providers know if injury occurs.


Hospitals Use VigiLanz to Support Big Patient Safety Improvements

Stepping Up Patient Safety with VigiLanz

Avoid adverse events, prevent and control infections and outbreaks, and promote opioid stewardship

Far too many patients are harmed due to medical errors and other safety issues. In fact, medical errors are the third leading cause of death in the United States. VigiLanz is helping hundreds of hospitals improve patient safety in several ways, including assisting with adverse event avoidance, infection and outbreak control, and opioid stewardship. Learn more about how three hospitals are using clinical surveillance technology to improve in these areas.

Hospitals Fight Back Against Preventable Medical Errors, Improve Patient Safety

The Unforgivable Metric: Avoidable Patient Errors…

…and What Hospitals Can Do About Them

Patients go to the hospital for healing, but despite the best intentions of clinical staff, far too many patients experience unintended harm.

The numbers are staggering. Medical errors are the third leading cause of death in the United States after heart disease and cancer. Today alone, 1,000 people will die because of a preventable hospital error.

Check out our short infographic to learn how real hospitals are using clinical surveillance to turn the tide against medical errors and other patient safety issues.

Integrating Clinical Alerts into Clinician Workflows: Houston Methodist’s Approach

Data can help physicians and pharmacists make smarter patient care decisions, but the way in which physicians receive that data plays a huge role in whether the information drives higher-value care.

Physicians benefit most from data that is:

  • Current;
  • Easily integrated into their workflows; and
  • Targeted to their specific needs at that moment in patient care.

Many health systems are struggling to meet these three objectives. In fact, turning data into actionable information is the most pressing health IT challenge healthcare organizations face, according to a recent survey of 100 healthcare executives by Managed Healthcare Executive.

At HIMSS 2019, Nicholas Desai, MD, system chief medical information officer at Houston Methodist, shared how his organization is addressing this challenge.

To view his full presentation, click here.

To download the PDF case study, click here.

Houston Methodist—which is made up of seven hospitals, eight emergency care centers, and a large network of more than 6,700 affiliated physicians and 675 employed primary care and specialty physicians—recently embarked on a 90-day pilot to test how integrating clinical alerts into its EMR workflow could help physicians and pharmacists make more cost-effective, higher quality care decisions.

About 130 clinicians and 38 pharmacists were involved in the pilot, said Desai, during his presentation at the VigiLanz booth on Wednesday, February 13.

The alerts were pulled from a variety of sources, including Houston Methodist’s own data and data from its partners, such as VigiLanz. The alerts were integrated into the EMR workflow via IllumiCare’s Smart Ribbon.

“The ribbon is an executable file that sits right on top of our [EMR]. It aggregates data and everything right from our [EMR], but the best part is it pulls it all together in one place,” said Desai. “I can call it up when I want it, I can force it to be passive or active.”

Two Tips for Effective Alert Integrations

  • When integrating alerts into the EMR, consider passive and active alerts that you want to make front and center. For example, if there are five drugs your organization is watching and monitoring closely, consider how you can use alerts to highlight those as top of mind for clinicians.
  • Bring various stakeholders to the table to help determine what type of alerts and data should be integrated. For example, if your organization’s PDMP task force is involved, it might reveal that integrating PDMP-related reports is key.

Pilot Results

The results of the pilot are impressive. The organization was able to shift the cost curve within the 90-day mark about $107,000, said Desai.

“Overall, we believe that in 2019, for this hospital, we have an opportunity of 4.5 percent reduction in our costs, which will lead to between $1.7 million and $2.8 million, just for one hospital,” he said. “As an organization, it’s upwards of what appears to be closer to in the ballpark of $18 [million], $19 [million], $20 million dollars.”  

Desai said the VigiLanz alerts in the Smart Ribbon are also extremely helpful to pharmacists, because they can see alerts directly in the EMR without needing to go into the VigiLanz app to view them.

“The reality here is we’re giving [clinicians] tools and working with partners like VigiLanz and Illumicare to really bring together the efficiency tools that our providers need,” said Desai. “That’s what matters.”

To learn how health systems are using clinical surveillance to support high-value care, read: “Clinical Surveillance: The Next Step in Value-Based Care.”

Perhaps most importantly, clinicians responded very favorably to the integrated alerts. “Seventy-two percent of doctors, at the end of our pilot said, ‘This is not just valuable, finally you’re giving me a tool that is meaningful,’” said Desai. “In every one of those conversations, cost was important, but not the only reason why they liked the tool. What they liked about it was that this allowed them to see things in a more holistic view in one place.”

This post has been updated from a post previously published on February 28, 2019.